Invenomic Capital Management LP Bausch & Lomb Corp Transaction History

Invenomic Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$13.6 - $17.06 $5.01 Million - $6.28 Million	368,384 Added 93.48%	762,451 $11.1 Million
Q1 2024 May 15, 2024	BUY	$13.68 - $17.6 $5.39 Million - $6.94 Million	394,067 New	394,067 $6.82 Million
Q1 2023 May 15, 2023	SELL	$15.67 - $18.91 $1.18 Million - $1.43 Million	-75,448 Reduced 8.61%	800,926 $13.9 Million
Q4 2022 Feb 14, 2023	BUY	$13.5 - $17.14 $3.99 Million - $5.07 Million	295,510 Added 50.87%	876,374 $13.6 Million
Q3 2022 Nov 14, 2022	SELL	$14.23 - $17.76 $234,524 - $292,702	-16,481 Reduced 2.76%	580,864 $8.91 Million
Q2 2022 Aug 15, 2022	BUY	$13.36 - $20.0 $7.98 Million - $11.9 Million	597,345 New	597,345 $9.1 Million

118

37.8M

116K

299K

Ticker BLCO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 350,000,000
Market Cap $6.84B
Description
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Invenomic Capital Management LP with notifications on news.